Change of Director's Interest Notice
Released
Released
Announcement PDF
Appendix 3Y
Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity: Resonance Health Ltd
ABN: 96 006 762 492
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for the purposes of section 205G of the Corporations Act.
Name of Director
Mitchell M Wells
Date of last notice
5 January 2023
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be
disclosed in this part.
Direct or indirect interest
Indirect
Nature of indirect interest
(including registered holder)
Sarah Ainslie Wells, wife of Mitchell M Wells
Note: Provide details of the circumstances giving rise to the relevant
interest.
Date of change
No. of securities held prior to change
20 Oct 2023
Direct - Mitchell M Wells: 1,000,000
Indirect - Sarah A Wells: Nil
Indirect - Biggles Pty Ltd ATF Biggles Investment
Trust: 1,830,000 unquoted Performance Rights
Class
ORD
Number acquired
610,000 on conversion of Performance Rights
Number disposed
Nil
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change
610,000 @ $0.06 = AUD $36,600
Direct - Mitchell M Wells: 1,000,000
Indirect - Sarah A Wells: 610,000
Indirect - Biggles Pty Ltd ATF Biggles Investment
Trust: 1,220,000 unquoted Performance Rights
+ See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
Appendix 3Y
Change of Director’s Interest Notice
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue
of securities under dividend reinvestment plan, participation in buyback
Conversion of Performance Rights on meeting
the specified vesting criteria.
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be
disclosed in this part.
Detail of contract
N/A
Nature of interest
N/A
Name of registered holder
(if issued securities)
N/A
Date of change
N/A
No. and class of securities to which
interest related prior to change
N/A
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
N/A
Interest disposed
N/A
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
Interest after change
N/A
N/A
Part 3 – +Closed period
Were the interests in the securities or contracts detailed
above traded during a +closed period where prior written No
clearance was required?
If so, was prior written clearance provided to allow the
N/A
trade to proceed during this period?
If prior written clearance was provided, on what date was
N/A
this provided?
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Share your feedback
Discover